Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Evaluate which tax lot harvesting approach—ETFs or mutual funds—yields lower taxes in retirement and aligns with your plan.
25,078 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A looked-at moment in media power and money: how a public challenge can ripple into legal fees, PR costs, and real-wo...
A growing crime trend links revenge plots to cryptocurrency payments. This article explains how digital money helped ...
SpaceX is growing fast, but its financing moves could change the risk profile for investors. This article breaks down...
Two consumer stars with very different paths battle for investors' attention. One mixes health-forward fast-casual ex...
Morningstar analysts warn SpaceX could be worth far less than its IPO price, focusing on profitability gaps and Starl...
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
Celebrity headlines can sway our wallets. This article digs into the money lessons behind the buzz, offering actionab...
Open Society Foundations committing $30 million over three years to support interfaith partnerships and protect commu...
A UFC fan event near the White House sparked headlines about an arrest, but authorities clarified there was none. Thi...